Literature DB >> 2794075

Prognostic variables in large bowel cancer.

J R Jass.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2794075      PMCID： PMC501813          DOI： 10.1136/jcp.42.9.1006-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  4 in total

1.  Feasibility of new prognostic classification for rectal cancer.

Authors:  S A Dundas; R W Laing; A O'Cathain; I Seddon; D N Slater; T J Stephenson; J C Underwood
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

Review 2.  Reporting colorectal cancer.

Authors:  J R Jass; B C Morson
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

3.  Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.

Authors:  T B Halvorsen; E Seim
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

4.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087
  4 in total
  3 in total

1.  CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients.

Authors:  J Kamińska; M M Kowalska; M P Nowacki; M G Chwaliński; A Rysińska; M Fuksiewicz
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.

Authors:  Rodrigo Oliva Perez; Bárbara Helou Bresciani; Cláudio Bresciani; Igor Proscurshim; Desiderio Kiss; Joaquim Gama-Rodrigues; Diego Daniel Pereira; Viviane Rawet; Ivan Cecconnello; Angelita Habr-Gama
Journal:  Int J Colorectal Dis       Date:  2008-05-06       Impact factor: 2.571

3.  Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.

Authors:  H Robson; E Anderson; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.